Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN14763786
ISRCTN14763786
Completed
未知

Improvement of Cognitive functions in sedentaRy schizophrEnic subjects following 1-year of guided Walking (CREW): a pilot study

niversity of Ferrara0 sites40 target enrollmentJanuary 26, 2021
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsSchizophreniaMental and Behavioural Disorders

Overview

Phase
未知
Intervention
Not specified
Conditions
Schizophrenia
Sponsor
niversity of Ferrara
Enrollment
40
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35337370/ (added 28/03/2022)

Registry
who.int
Start Date
January 26, 2021
End Date
December 22, 2020
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Ferrara

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients diagnosed with schizophrenia since at least 1 year
  • •2\. On antipsychotic medications with the same therapeutic regimen for at least 3 months before enrolment
  • •3\. Free of symptomatic peripheral arterial occlusive disease and cardiovascular, pulmonary, neurological, metabolic, and orthopaedic disorders that could interfere with the walking activity

Exclusion Criteria

  • •1\. Recent modification of therapeutic regimen
  • •2\. Presence of symptomatic peripheral arterial occlusive disease and cardiovascular, pulmonary, neurological, metabolic, and orthopaedic disorders that could interfere with the walking activity

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
The effect of biofeedback therapy in psychiatric rehabilitatioSchizophreniaMental and Behavioural Disorders
ISRCTN78612833Medical University of Lublin62
Withdrawn
Not Applicable
tDCS to Enhance Cognitive Training in Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
NCT04261556University of Milano Bicocca
Completed
Not Applicable
A study on cognitive dysfunction improvement of aripiprazole for Japanese schizophrenia patients.schzophrenia
JPRN-UMIN000013765Division of Neuropsychiatry, Department of Brain and Neuroscience, Faculty of Medecine, Tottori University100
Completed
Not Applicable
Study on the effect of improving cognitive function by BetahistineDementia of the Alzheimer type
JPRN-UMIN000015110Kyoto University Graduate School of Medicine43
Completed
Not Applicable
A confirmation study for improving cognitive function with consumption of the test foodHealthy Japanese subjects
JPRN-UMIN000045040ORTHOMEDICO Inc.40